Mettler Toledo (MTD) fundamentals: P/E, valuation, undervalued?
Mettler Toledo · Health Care · ref. ETF XLV · price $1407.43
In short — Mettler Toledo trades at 31.7× earnings (P/E), 27.2× forward, with a net margin of 21.9 % and revenue growth of +5 %. Read: Fairly valued (P/E 27 in line with ~18% growth (PEG 1.5)).
Is Mettler Toledo stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$1407.43+9.7% over range
Aug 28, 25low $1025.53 · high $1506.02Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 9 analysts
Valuation : Fairly valued — P/E 27 in line with ~18% growth (PEG 1.5)
Valuation
31.7
P/E (price/earnings)
27.2
Forward P/E
1.73
PEG
2199.1
Price/book (P/B)
$28.2B
Market cap
44.33
EPS
Profitability & growth
21.9 %
Net margin
+5 %
Revenue growth
+18 %
Earnings growth
$2.1B
Total debt
Mettler Toledo income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $3.9B | $873M | 22.3 % |
| 2023 | $3.8B | $789M | 20.8 % |
| 2024 | $3.9B | $863M | 22.3 % |
| 2025 | $4.0B | $869M | 21.6 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Mettler Toledo's P/E and is the stock undervalued? What's a good P/E?
Mettler Toledo's P/E is 31.7 (forward 27.2). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".
Is Mettler Toledo profitable?
Mettler Toledo has a net margin of 21.9 % (EPS 44.33). The company is profitable.
Is MTD stock expensive?
Our read: "Fairly valued" — P/E 27 in line with ~18% growth (PEG 1.5). Cross-check with growth and sector.
💬 A question about Mettler Toledo? The JPI assistant answers using our backtest data.
Keep exploring Mettler Toledo